Rocket One Inc. Increase (Decrease) in Accrued Liabilities
Rocket One Inc. (RKTO) reported Increase (Decrease) in Accrued Liabilities of -$1.54 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2020-03-02
- Rocket One Inc. increase (decrease) in accrued liabilities for the quarter ending 2018-12-31 was $0.00.
- Rocket One Inc. increase (decrease) in accrued liabilities for the quarter ending 2018-09-30 was $0.00.
- Rocket One Inc. increase (decrease) in accrued liabilities for fiscal 2018 was -$1.54K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 8 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | -$1.54K 10-K · filed 2020-03-02 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$1.54K 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | -$1.54K 10-Q · filed 2019-08-14 | ||||
| 2017-12-31 | $1.54K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |